Liu et al. have detected that knockdown of IGF2BP1 expression level through applying a CRISPR/Cas9 genome editing system could play a crucial role in repressing the expression levels of IGF2, Gli1, CD44, and Myc in skin SCC cells through which tumor cell proliferation and survival were suppressed considerably. Here, IGF2BP1 is linked to neoplasm.